Andy Pasternak, EVP, Chief Strategy Officer at Horizon Therapeutics Public Ltd Co (HZNP), sold 60,338 shares at $112.60 ($6.8M) on 2022-12-13, disclosed to the SEC on 2022-12-14.
Open-market sale of $6.8M HZNP by EVP, Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.60 | 6,918 | $779K | 11.5% |
| 2 | $112.60 | 6,918 | $779K | 11.5% |
| 3 | $112.61 | 23,251 | $2.6M | 38.5% |
| 4 | $112.61 | 23,251 | $2.6M | 38.5% |
| Total | $112.61 avg | 60,338 | $6.8M | 100% |
| Filing → |
| HZNP | SELL | 2022-06-13 | $130K | — | Filing → |
| HZNP | SELL | 2022-02-18 | $249K | — | Filing → |
| HZNP | SELL | 2022-01-06 | $1.4M | — | Filing → |